tiprankstipranks
Trending News
More News >
Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT
US Market

Adaptive Biotechnologies (ADPT) Financial Statements

Compare
1,013 Followers

Adaptive Biotechnologies Financial Overview

Adaptive Biotechnologies's market cap is currently $2.71B. The company's EPS TTM is $0.06; its P/E ratio is -32.56; Adaptive Biotechnologies is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 178.96M$ 170.28M$ 185.31M$ 154.34M$ 98.38M
Gross Profit$ 106.88M$ 94.72M$ 127.40M$ 105.04M$ 75.85M
Operating Income$ -162.55M$ -227.03M$ -200.19M$ -208.97M$ -152.82M
EBITDA$ -128.76M$ -189.27M$ -175.21M$ -193.34M$ -144.34M
Net Income$ -159.49M$ -225.25M$ -200.19M$ -207.28M$ -146.23M
Balance Sheet
Cash & Short-Term Investments$ 222.29M$ 346.40M$ 498.20M$ 353.06M$ 688.27M
Total Assets$ 539.38M$ 661.13M$ 856.62M$ 923.34M$ 1.12B
Total Debt$ 89.39M$ 98.77M$ 108.00M$ 111.74M$ 107.86M
Net Debt$ 41.47M$ 33.71M$ 17.97M$ -27.32M$ -15.57M
Total Liabilities$ 336.89M$ 352.86M$ 392.52M$ 319.24M$ 373.15M
Stockholders' Equity$ 202.71M$ 308.40M$ 464.17M$ 603.99M$ 743.27M
Cash Flow
Free Cash Flow$ -98.88M$ -167.02M$ -200.29M$ -254.47M$ -168.49M
Operating Cash Flow$ -95.21M$ -156.32M$ -183.94M$ -192.73M$ -149.68M
Investing Cash Flow$ 77.79M$ 129.65M$ 2.90M$ 181.21M$ -117.04M
Financing Cash Flow$ 241.00K$ 2.25M$ 132.26M$ 27.15M$ 293.59M
Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

Adaptive Biotechnologies Debt to Assets

Adaptive Biotechnologies Cash Flow

Adaptive Biotechnologies Forecast EPS vs Actual EPS